COVID-19 Impact on Global Anticoagulant Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 95 pages | ID: C30EC25E6716EN
QYResearch

Abstracts

This report focuses on the global Anticoagulant Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anticoagulant Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bristol-Myers Squibb
• Bayer
• Pfizer
• Johnson & Johnson
• Sanofi
• Boehringer Ingelheim
• Daiichi Sankyo
• ...

Market segment by Type, the product can be split into

• NOACs
• Heparin
• Warfarin
• Others

Market segment by Application, split into

• Hospital
• Drugs Stores
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Anticoagulant Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Anticoagulant Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anticoagulant Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Anticoagulant Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Anticoagulant Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 NOACs
  1.4.3 Heparin
  1.4.4 Warfarin
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Anticoagulant Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Drugs Stores
  1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Anticoagulant Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Anticoagulant Treatment Industry
    1.6.1.1 Anticoagulant Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Anticoagulant Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Anticoagulant Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Anticoagulant Treatment Market Perspective (2015-2026)
2.2 Anticoagulant Treatment Growth Trends by Regions
  2.2.1 Anticoagulant Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Anticoagulant Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Anticoagulant Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Anticoagulant Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Anticoagulant Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Anticoagulant Treatment Players by Market Size
  3.1.1 Global Top Anticoagulant Treatment Players by Revenue (2015-2020)
  3.1.2 Global Anticoagulant Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Anticoagulant Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Anticoagulant Treatment Market Concentration Ratio
  3.2.1 Global Anticoagulant Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Anticoagulant Treatment Revenue in 2019
3.3 Anticoagulant Treatment Key Players Head office and Area Served
3.4 Key Players Anticoagulant Treatment Product Solution and Service
3.5 Date of Enter into Anticoagulant Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Anticoagulant Treatment Historic Market Size by Type (2015-2020)
4.2 Global Anticoagulant Treatment Forecasted Market Size by Type (2021-2026)

5 ANTICOAGULANT TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Anticoagulant Treatment Market Size by Application (2015-2020)
5.2 Global Anticoagulant Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Anticoagulant Treatment Market Size (2015-2020)
6.2 Anticoagulant Treatment Key Players in North America (2019-2020)
6.3 North America Anticoagulant Treatment Market Size by Type (2015-2020)
6.4 North America Anticoagulant Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Anticoagulant Treatment Market Size (2015-2020)
7.2 Anticoagulant Treatment Key Players in Europe (2019-2020)
7.3 Europe Anticoagulant Treatment Market Size by Type (2015-2020)
7.4 Europe Anticoagulant Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Anticoagulant Treatment Market Size (2015-2020)
8.2 Anticoagulant Treatment Key Players in China (2019-2020)
8.3 China Anticoagulant Treatment Market Size by Type (2015-2020)
8.4 China Anticoagulant Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Anticoagulant Treatment Market Size (2015-2020)
9.2 Anticoagulant Treatment Key Players in Japan (2019-2020)
9.3 Japan Anticoagulant Treatment Market Size by Type (2015-2020)
9.4 Japan Anticoagulant Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Anticoagulant Treatment Market Size (2015-2020)
10.2 Anticoagulant Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Anticoagulant Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Anticoagulant Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Anticoagulant Treatment Market Size (2015-2020)
11.2 Anticoagulant Treatment Key Players in India (2019-2020)
11.3 India Anticoagulant Treatment Market Size by Type (2015-2020)
11.4 India Anticoagulant Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Anticoagulant Treatment Market Size (2015-2020)
12.2 Anticoagulant Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Anticoagulant Treatment Market Size by Type (2015-2020)
12.4 Central & South America Anticoagulant Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bristol-Myers Squibb
  13.1.1 Bristol-Myers Squibb Company Details
  13.1.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.1.3 Bristol-Myers Squibb Anticoagulant Treatment Introduction
  13.1.4 Bristol-Myers Squibb Revenue in Anticoagulant Treatment Business (2015-2020))
  13.1.5 Bristol-Myers Squibb Recent Development
13.2 Bayer
  13.2.1 Bayer Company Details
  13.2.2 Bayer Business Overview and Its Total Revenue
  13.2.3 Bayer Anticoagulant Treatment Introduction
  13.2.4 Bayer Revenue in Anticoagulant Treatment Business (2015-2020)
  13.2.5 Bayer Recent Development
13.3 Pfizer
  13.3.1 Pfizer Company Details
  13.3.2 Pfizer Business Overview and Its Total Revenue
  13.3.3 Pfizer Anticoagulant Treatment Introduction
  13.3.4 Pfizer Revenue in Anticoagulant Treatment Business (2015-2020)
  13.3.5 Pfizer Recent Development
13.4 Johnson & Johnson
  13.4.1 Johnson & Johnson Company Details
  13.4.2 Johnson & Johnson Business Overview and Its Total Revenue
  13.4.3 Johnson & Johnson Anticoagulant Treatment Introduction
  13.4.4 Johnson & Johnson Revenue in Anticoagulant Treatment Business (2015-2020)
  13.4.5 Johnson & Johnson Recent Development
13.5 Sanofi
  13.5.1 Sanofi Company Details
  13.5.2 Sanofi Business Overview and Its Total Revenue
  13.5.3 Sanofi Anticoagulant Treatment Introduction
  13.5.4 Sanofi Revenue in Anticoagulant Treatment Business (2015-2020)
  13.5.5 Sanofi Recent Development
13.6 Boehringer Ingelheim
  13.6.1 Boehringer Ingelheim Company Details
  13.6.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.6.3 Boehringer Ingelheim Anticoagulant Treatment Introduction
  13.6.4 Boehringer Ingelheim Revenue in Anticoagulant Treatment Business (2015-2020)
  13.6.5 Boehringer Ingelheim Recent Development
13.7 Daiichi Sankyo
  13.7.1 Daiichi Sankyo Company Details
  13.7.2 Daiichi Sankyo Business Overview and Its Total Revenue
  13.7.3 Daiichi Sankyo Anticoagulant Treatment Introduction
  13.7.4 Daiichi Sankyo Revenue in Anticoagulant Treatment Business (2015-2020)
  13.7.5 Daiichi Sankyo Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Anticoagulant Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Anticoagulant Treatment Revenue
Table 3. Ranking of Global Top Anticoagulant Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Anticoagulant Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of NOACs
Table 6. Key Players of Heparin
Table 7. Key Players of Warfarin
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four Anticoagulant Treatment Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Anticoagulant Treatment Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Anticoagulant Treatment Players to Combat Covid-19 Impact
Table 14. Global Anticoagulant Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Anticoagulant Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Anticoagulant Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Anticoagulant Treatment Market Share by Regions (2015-2020)
Table 18. Global Anticoagulant Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Anticoagulant Treatment Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Anticoagulant Treatment Market Growth Strategy
Table 24. Main Points Interviewed from Key Anticoagulant Treatment Players
Table 25. Global Anticoagulant Treatment Revenue by Players (2015-2020) (Million US$)
Table 26. Global Anticoagulant Treatment Market Share by Players (2015-2020)
Table 27. Global Top Anticoagulant Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulant Treatment as of 2019)
Table 28. Global Anticoagulant Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Anticoagulant Treatment Product Solution and Service
Table 31. Date of Enter into Anticoagulant Treatment Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Anticoagulant Treatment Market Size by Type (2015-2020) (Million US$)
Table 34. Global Anticoagulant Treatment Market Size Share by Type (2015-2020)
Table 35. Global Anticoagulant Treatment Revenue Market Share by Type (2021-2026)
Table 36. Global Anticoagulant Treatment Market Size Share by Application (2015-2020)
Table 37. Global Anticoagulant Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. Global Anticoagulant Treatment Market Size Share by Application (2021-2026)
Table 39. North America Key Players Anticoagulant Treatment Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Anticoagulant Treatment Market Share (2019-2020)
Table 41. North America Anticoagulant Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. North America Anticoagulant Treatment Market Share by Type (2015-2020)
Table 43. North America Anticoagulant Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. North America Anticoagulant Treatment Market Share by Application (2015-2020)
Table 45. Europe Key Players Anticoagulant Treatment Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Anticoagulant Treatment Market Share (2019-2020)
Table 47. Europe Anticoagulant Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Anticoagulant Treatment Market Share by Type (2015-2020)
Table 49. Europe Anticoagulant Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Anticoagulant Treatment Market Share by Application (2015-2020)
Table 51. China Key Players Anticoagulant Treatment Revenue (2019-2020) (Million US$)
Table 52. China Key Players Anticoagulant Treatment Market Share (2019-2020)
Table 53. China Anticoagulant Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. China Anticoagulant Treatment Market Share by Type (2015-2020)
Table 55. China Anticoagulant Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. China Anticoagulant Treatment Market Share by Application (2015-2020)
Table 57. Japan Key Players Anticoagulant Treatment Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Anticoagulant Treatment Market Share (2019-2020)
Table 59. Japan Anticoagulant Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Anticoagulant Treatment Market Share by Type (2015-2020)
Table 61. Japan Anticoagulant Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Anticoagulant Treatment Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Anticoagulant Treatment Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Anticoagulant Treatment Market Share (2019-2020)
Table 65. Southeast Asia Anticoagulant Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Anticoagulant Treatment Market Share by Type (2015-2020)
Table 67. Southeast Asia Anticoagulant Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Anticoagulant Treatment Market Share by Application (2015-2020)
Table 69. India Key Players Anticoagulant Treatment Revenue (2019-2020) (Million US$)
Table 70. India Key Players Anticoagulant Treatment Market Share (2019-2020)
Table 71. India Anticoagulant Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. India Anticoagulant Treatment Market Share by Type (2015-2020)
Table 73. India Anticoagulant Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. India Anticoagulant Treatment Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Anticoagulant Treatment Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Anticoagulant Treatment Market Share (2019-2020)
Table 77. Central & South America Anticoagulant Treatment Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Anticoagulant Treatment Market Share by Type (2015-2020)
Table 79. Central & South America Anticoagulant Treatment Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Anticoagulant Treatment Market Share by Application (2015-2020)
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Product
Table 84. Bristol-Myers Squibb Revenue in Anticoagulant Treatment Business (2015-2020) (Million US$)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Product
Table 89. Bayer Revenue in Anticoagulant Treatment Business (2015-2020) (Million US$)
Table 90. Bayer Recent Development
Table 91. Pfizer Company Details
Table 92. Pfizer Business Overview
Table 93. Pfizer Product
Table 94. Pfizer Revenue in Anticoagulant Treatment Business (2015-2020) (Million US$)
Table 95. Pfizer Recent Development
Table 96. Johnson & Johnson Company Details
Table 97. Johnson & Johnson Business Overview
Table 98. Johnson & Johnson Product
Table 99. Johnson & Johnson Revenue in Anticoagulant Treatment Business (2015-2020) (Million US$)
Table 100. Johnson & Johnson Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Product
Table 104. Sanofi Revenue in Anticoagulant Treatment Business (2015-2020) (Million US$)
Table 105. Sanofi Recent Development
Table 106. Boehringer Ingelheim Company Details
Table 107. Boehringer Ingelheim Business Overview
Table 108. Boehringer Ingelheim Product
Table 109. Boehringer Ingelheim Revenue in Anticoagulant Treatment Business (2015-2020) (Million US$)
Table 110. Boehringer Ingelheim Recent Development
Table 111. Daiichi Sankyo Company Details
Table 112. Daiichi Sankyo Business Overview
Table 113. Daiichi Sankyo Product
Table 114. Daiichi Sankyo Revenue in Anticoagulant Treatment Business (2015-2020) (Million US$)
Table 115. Daiichi Sankyo Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Anticoagulant Treatment Market Share by Type: 2020 VS 2026
Figure 2. NOACs Features
Figure 3. Heparin Features
Figure 4. Warfarin Features
Figure 5. Others Features
Figure 6. Global Anticoagulant Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Drugs Stores Case Studies
Figure 9. Other Case Studies
Figure 10. Anticoagulant Treatment Report Years Considered
Figure 11. Global Anticoagulant Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Anticoagulant Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Anticoagulant Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Anticoagulant Treatment Market Share by Players in 2019
Figure 16. Global Top Anticoagulant Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anticoagulant Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Anticoagulant Treatment Revenue in 2019
Figure 18. North America Anticoagulant Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Anticoagulant Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Anticoagulant Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Anticoagulant Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Anticoagulant Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Anticoagulant Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Anticoagulant Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Bristol-Myers Squibb Revenue Growth Rate in Anticoagulant Treatment Business (2015-2020)
Figure 27. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Bayer Revenue Growth Rate in Anticoagulant Treatment Business (2015-2020)
Figure 29. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Pfizer Revenue Growth Rate in Anticoagulant Treatment Business (2015-2020)
Figure 31. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Johnson & Johnson Revenue Growth Rate in Anticoagulant Treatment Business (2015-2020)
Figure 33. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Sanofi Revenue Growth Rate in Anticoagulant Treatment Business (2015-2020)
Figure 35. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Boehringer Ingelheim Revenue Growth Rate in Anticoagulant Treatment Business (2015-2020)
Figure 37. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Daiichi Sankyo Revenue Growth Rate in Anticoagulant Treatment Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed